UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For Quarterly Period Ended March 30, 2002 Commission File Number 0-21068
-------------- -------
Sight Resource Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 04-3181524
--------------------------------------------------------------------------------
(State or other jurisdiction (I.R.S. Employer Identification No.)
of incorporation or organization)
6725 Miami Avenue, Suite 102, Cincinnati, OH 45243
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(513) 527-9700
--------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
N/A
--------------------------------------------------------------------------------
(Former name, former address and former fiscal
year, if changed since the last report)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes X No______
------
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date:
On May 10, 2002, 30,667,709 shares (does not include 30,600 shares held as
treasury stock) of common stock, par value $0.01 per share, were outstanding.
SIGHT RESOURCE CORPORATION
INDEX
PART I. FINANCIAL INFORMATION Page
----
Item 1. Financial Statements
Consolidated Balance Sheets as of March 30, 2002 and
December 29, 2001 1
Consolidated Statements of Operations for the Three
Months Ended March 30, 2002 and March 31, 2001 2
Consolidated Statements of Cash Flows for the Three
Months Ended March 30, 2002 and March 31, 2001 3
Notes to Consolidated Financial Statements 4
Item 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations 7
Item 3. Quantitative and Qualitative Disclosures about Market Risk 17
PART II. OTHER INFORMATION
Item 1. Legal Proceedings 17
Item 2. Changes in Securities and Use of Proceeds 17
Signatures 18
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
SIGHT RESOURCE CORPORATION
Consolidated Balance Sheets
(In thousands, except share and per share data)
As of As of
March 30, 2002 December 29, 2001
----------------------- --------------------
Assets (unaudited)
Current assets:
Cash and cash equivalents $ 1,065 $ 1,356
Accounts receivable, net of allowance of $1,758 and $1,915,
respectively 3,036 2,613
Inventories 4,907 4,666
Prepaid expenses and other current assets 420 395
----------------------- --------------------
Total current assets 9,428 9,030
----------------------- --------------------
Property and equipment, net 2,539 2,729
Other assets:
Intangible assets, net 19,605 19,770
Web site development 2,288 2,288
Other assets 120 127
----------------------- --------------------
Total assets $ 33,980 $ 33,944
======================= ====================
Liabilities and Stockholders' Equity
Current liabilities:
Revolver notes payable $ 2,500 $ 2,500
Current portion of long term debt 5,659 5,979
Current portion of capital leases 10 10
Accounts payable 5,741 5,789
Accrued expenses 1,792 1,813
Dividends payable 127 -
---------------------- --------------------
Total current liabilities 15,829 16,091
---------------------- --------------------
Non-current liabilities:
Long term debt, less current maturities 929 928
Capital leases 15 17
----------------------- --------------------
Total non-current liabilities 944 945
----------------------- --------------------
Series B redeemable convertible preferred stock
1,452,119 shares issued and outstanding 6,535 6,535
Stockholders' equity:
Preferred Stock, $.01 par value. Authorized 5,000,000
shares; no shares of Series A issued and outstanding -- --
Common Stock, $.01 par value. Authorized 50,000,000
shares; 30,698,309 at March 30, 2002
and 29,597,703 at December 29, 2001 shares
issued and outstanding 307 296
Additional paid-in capital 41,672 41,810
Treasury stock at cost, 30,600 shares at March 30, 2002
and December 29, 2001 (137) (137)
Accumulated deficit (31,170) (31,596)
----------------------- -------------------
Total stockholders' equity 10,672 10,373
----------------------- -------------------
$33,980 $33,944
======================== ====================
See accompanying notes to consolidated financial statements.
1
SIGHT RESOURCE CORPORATION
Consolidated Statements of Operations
(In thousands, except share and per share data)
Three Months Ended
-------------------------------------------------
March 30, 2002 March 31, 2001
-------------- --------------
(unaudited) (unaudited)
Net revenue $ 15,276 $ 16,059
Cost of revenue 4,367 4,918
------------ -----------
Gross profit 10,909 11,141
Selling, general and administrative expenses 10,290 11,189
------------ -----------
Income (loss) from operations 619 (48)
Interest expense, net (189) (236)
------------ -----------
Income (loss) before taxes 430 (284)
Income tax expense 4 21
------------ -----------
Net income (loss) 426 (305)
------------ -----------
Dividends on redeemable convertible preferred stock 127 -
------------ -----------
Net income (loss) attributable to common stockholders $ 299 $ (305)
------------ -----------
Basic and diluted income (loss) per common share $ 0.01 $ (0.03)
------------ -----------
Weighted average number of common shares outstanding:
Basic 29,961,000 9,260,000
------------ -----------
Diluted 31,952,000 9,260,000
------------ -----------
See accompanying notes to consolidated financial statements.
2
SIGHT RESOURCE CORPORATION
Consolidated Statements of Cash Flows
(In thousands)
Three Months Ended
-----------------------------------------
March 30, 2002 March 31, 2001
-------------------- --------------------
(unaudited)
Operating activities:
Net income (loss) $ 426 $ (305)
Adjustments to reconcile net loss to net cash provided by operating
activities:
Depreciation and amortization 466 915
Amortization and write-off of deferred financing costs -- 57
Changes in operating assets and liabilities:
Accounts receivable (423) (210)
Inventories (241) 669
Prepaid expenses and other current assets (25) (296)
Accounts payable and accrued expenses (71) (317)
-------------- --------------
Net cash provided by operating activities 132 513
-------------- --------------
Investing activities:
Purchases of property and equipment (111) (124)
Other assets (liabilities) 7 (117)
-------------- --------------
Net cash used in investing activities (104) (241)
-------------- --------------
Financing activities:
Principal payments (319) (12)
-------------- --------------
Net cash used in financing activities (319) (12)
-------------- --------------
Net increase (decrease) in cash and cash equivalents (291) 260
Cash and cash equivalents, beginning of period 1,356 532
-------------- --------------
Cash and cash equivalents, end of period $ 1,065 $ 792
============== ==============
Supplementary cash flow information:
Interest paid $ 231 $ 241
Income taxes paid $ 21 $ 49
See accompanying notes to consolidated financial statements.
3
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(1) THE COMPANY
(a) Nature of Business
Sight Resource Corporation (the "Company") manufactures, distributes and
sells eyewear and related products and services.
(b) Eyeshop Merger
In July 2001, the Company merged with eyeshop.com, inc. ("Eyeshop"), an
early-stage optical development company established by E. Dean Butler in late
1999. Concurrent with the merger, there were two Common Stock Purchase
Agreements whereby the former shareholders of Eyeshop purchased additional
shares of the Company. It was anticipated that, following the merger, available
cash resources of the combined companies would be devoted to continuation and
improvement of the business of the Company, with a decision to be made at a
future date as to when the Eyeshop development activities should be resumed. As
of March 30, 2002, no decision had been made to resume Eyeshop development
activities.
Pursuant to a merger agreement, former Eyeshop stockholders are also
entitled to receive additional shares of the Company's common stock if and when
certain options, warrants and other rights to receive the Company's common stock
that were held by the Company's security holders as of May 23, 2001 are
exercised. The Company issued a total of 7,306,662 shares of common stock to
former Eyeshop stockholders and assumed 1,757,096 stock options in connection
with the merger.
Collectively, the former stockholders of Eyeshop together with the common
stock purchasers associated with Eyeshop held approximately 18,876,162 shares of
the Company's common stock immediately after the merger and the common stock
financings, or approximately 64% of the Company's issued and outstanding common
stock and approximately 61% of the Company's issued and outstanding voting
securities.
The Company has completed its accounting for the merger. The treatment, for
accounting purposes, was considered to be a purchase of Eyeshop's assets and
assumption of Eyeshop's liabilities by the Company. The aggregate purchase price
was $2,054,000 and the costs of the assets acquired and liabilities assumed have
been allocated on the basis of the estimated fair value of the net assets
required. There was no goodwill provided in the transaction.
4
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements have been prepared by
the Company without audit, pursuant to the rules and regulations of the United
States Securities and Exchange Commission the ("SEC"). In the opinion of the
Company, these consolidated financial statements contain all adjustments
(consisting of only normal, recurring adjustments) necessary to present fairly
the Company's financial position as of March 30, 2002 and the results of its
operations and cash flows for the periods presented.
The Company's fiscal year ends on the last Saturday in December. Each
quarter represents a 13-week period, except during a 53-week year in which case
one quarter represents a 14-week period. The quarters ended March 30, 2002 and
March 31, 2001 were 13-week periods. Fiscal years 2002 and 2001 are 52-week
fiscal years.
The accompanying consolidated financial statements and related notes should
be read in conjunction with the audited consolidated financial statements which
are contained in the Company's Annual Report on Form 10-K, as amended on Form
10-K/A, for the year ended December 29, 2001.
(3) GOODWILL AND INTANGIBLE ASSETS
The Company adopted the provisions of Statement of Financial Accounting
Standards No. 141, Business Combinations ("Statement 141") effective July 1,
2001 and Statement No. 142, Goodwill and Other Intangible Assets ("Statement
142"), effective December 30, 2001. Statement 141 addresses financial accounting
and reporting for business combinations requiring the use of the purchase method
of accounting and reporting for goodwill and other intangible assets requiring
that goodwill and intangible assets with indefinite useful lives no longer be
amortized, but instead tested for impairment at least annually in accordance
with the provisions of Statement 142. The Company has up to six months from the
adoption of Statement 142 to determine the fair value of each reporting unit and
compare it to the reporting unit's carrying amount. Statement 142 also requires
intangible assets with estimated useful lives be amortized over their respective
useful life to their estimated residual values, and reviewed for impairment. As
of March 30, goodwill had a value of $14,305,000 and other intangibles with a
definite useful life value of $5,300,000.
Based on preliminary independent third party enterprise valuations of each
of the Company's reporting units, the Company does not expect to recognize any
impairment of its goodwill and intangible assets upon adoption of Statement 142.
The Company will have its initial review of Statement 142 complete during the
second quarter 2002.
In the first three months of 2001, $261,000 of goodwill amortization was
included in selling, general and administrative expenses. The net loss for the
first three months of 2001 without goodwill amortization would have been
$44,000. No goodwill amortization was incurred during the first quarter of 2002.
For the year ended December 29, 2001, goodwill amortization of $1,046,000 was
included in selling, general and administrative expenses. The net loss for the
year ended December 29, 2001 without goodwill amortization would have been
$4,441,000. In accordance with Statement 142, the Company will test each
reporting unit's goodwill for impairment as of end of the fiscal year.
5
SIGHT RESOURCE CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(4) EARNINGS PER SHARE
The following table provides a reconciliation of the numerators and
denominators of the basic and diluted income (loss) per share
computations for the three months ended March 30, 2002 and March 31,
2001:
Three Months Ended
---------------------------------------
March 30, 2002 March 31, 2001
--------------- ---------------
(In thousands, except share and per share data)
Basic Income (Loss) Per Share
Net income (loss) $ 426 $ (305)
------------------- ------------------
Net income (loss) available to common stockholders
299 (305)
=================== ==================
Weighted average common shares outstanding 29,961,000 9,260,000
Net income (loss) per share $ 0.01 $(0.03)
=================== ==================
Diluted Income (Loss) Per Share
Net income (loss) $ 426 $ (305)
------------------- ------------------
Net income (loss) available to common stockholders
299 (305)
=================== ==================
Weighted average common shares outstanding 29,961,000 9,260,000
Convertible preferred stock 0 0
Pro Rata Portion of Kent Common Stock 738,000 0
Options and warrants 1,253,000 0
------------------- ------------------
Weighted average common shares outstanding and
potential shares 31,952,000 9,260,000
=================== ==================
Net income (loss) per share $ 0.01 $(0.03)
=================== ==================
Outstanding options, warrants and convertible preferred stock were not
included in the computation of diluted loss per share for the three months ended
March 30, 2002 and March 31, 2001, because they would have been antidilutive.
The following table presents the number of shares of common stock underlying
outstanding options, warrants and convertible preferred stock, which shares were
not included in such computation of diluted loss per share.
Three Months Ended
---------------------------------------
March 30, 2002 March 31, 2001
----------------- -----------------
Options 4,449,500 0
Warrants 942,568 0
Convertible preferred stock 3,243,900 1,452,119
------------------ ------------------
Total 8,635,968 1,452,119
================== ==================
6
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
OVERVIEW
The Company manufactures, distributes and sells eyewear and related
products and services. As of March 30, 2002, the Company's operations consisted
of 116 eye care centers, and one optical laboratory and distribution center, and
was one of the fifteen largest providers in the United States based upon annual
sales. The Company's eye care centers operate primarily under the brand names
Cambridge Eye Doctors, E.B. Brown Opticians, Eyeglass Emporium, Kent Optical,
Shawnee Optical, Vision Plaza, and Vision World. The Company also provides, or
where necessary to comply with applicable law, administers the business
functions of optometrists, ophthalmologists and professional corporations that
provide, vision related professional services.
The Company operates one optical laboratory and distribution center. The
regional optical laboratory provides complete services to the Company's eye care
centers, including polishing, cutting and edging, tempering, tinting and coating
of ophthalmic lenses. The distribution center provides and maintains an
inventory of all accessories and supplies necessary to operate an eye care
center, as well as "ready made" eye care products, including contact lenses and
related supplies. The inventory of eyeglass lenses, frames, contact lenses,
accessories and supplies is acquired through a number of sources, domestic and
foreign. Management believes that the optical laboratory and distribution center
has the capacity to accommodate additional multi-site eye care centers. In early
2001, the Company operated two regional optical laboratories and three
distribution centers. During 2001, one laboratory and two distribution centers
were closed and their operations were consolidated into the remaining laboratory
and distribution center. The laboratory and distribution centers were closed in
an effort for the Company to realize greater operating efficiencies from lower
inventories and lower payroll costs.
The Company's results of operations include the accounts of the Company,
its wholly-owned subsidiaries and four professional corporations ("PCs") in
which the Company's subsidiaries assume the financial risks and rewards of such
entities. The Company has no direct equity ownership in the PCs since the
outstanding voting capital stock of each of the PCs is 100% owned by a licensed
optometrist (the "nominee shareholder") who has, in turn, executed a Stock
Restrictions and Pledge Agreement (a "Pledge Agreement") in favor of a
subsidiary of the Company. Each Pledge Agreement contains provisions that
provide the Company with the ability at all times to cause a change in the
nominee shareholder for an unlimited number of times, at nominal cost. For
example, if (i) the employment of the nominee shareholder is terminated by the
PC or by the Company (including its subsidiaries) or (ii) the Company determines
that the nominee shareholder is impairing or rendering less-than-optimal the
Company's business management and administration of the PC, then the Company has
the right to require the existing nominee shareholder to sell all of the
outstanding stock of the PC to another person eligible to serve as a new nominee
shareholder. The purchase price for a sale of the PC's stock is equal to the
7
aggregate book value of the PC, which will always be a nominal cost because each
PC operates and expects to continue to operate at an almost break-even level
generating a nominal profit, if any at all.
RESULTS OF OPERATIONS
Three Months Ended March 30, 2002 and March 31, 2001
Net Revenue. During the three months ended March 30, 2002, the Company
generated net revenue of $15,276,000, as compared to net revenue of $16,059,000
for the three months ended March 30, 2001. The decrease of $783,000, or 4.9%, in
net revenue primarily relates to six less eye care centers operating during the
three months ended March 30, 2002 as compared to the corresponding period in
2001.
Cost of Revenue. Cost of revenue decreased from $4,918,000 for the
operation of the Company's 122 eye care centers during the three months ended
March 31, 2001 to $4,367,000 for the operation of the Company's 116 eye care
centers during the three months ended March 30, 2002. Cost of revenue as a
percentage of net revenue decreased from 30.6% for the three months ended March
31, 2001 to 28.6% for the three months ended March 30, 2002. The improvement as
a percentage of net revenue primarily reflects the consolidation of optical
laboratory operations, improved margins on frames and slightly higher eye exam
revenue. Cost of revenue principally consisted of the cost of manufacturing,
purchasing and distributing optical products to customers of the Company.
Selling, General and Administrative Expenses. Selling, general and
administrative expenses decreased to $10,290,000 for the three months ended
March 30, 2002 from $11,189,000 for the three months ended March 31, 2001. The
decrease of $899,000 primarily relates to reduced staffing levels and lower
amortization expenses of $261,000 resulting from the Company's adoption of
Statement 142. Selling, general and administrative expenses, as a percentage of
net revenue, decreased from 69.7% for the three months ended March 31, 2001 to
67.4% for the three months ended March 30, 2002.
The Company adopted Statement 142 as of December 30, 2001 and has up to six
months from the date of adoption to complete its determination of the fair value
of each of the Company's reporting units. Based on preliminary independent third
party enterprise valuations of each of the Company's reporting units, the
Company does not expect to recognize any impairment of its goodwill and
intangible assets upon completion of such determinations. Further, under the new
guidelines set forth in Statement 142, the Company ceased amortization of its
goodwill, which reduced selling, general and administrative expenses for the
three months ended March 30, 2002 by $261,000 compared to the three months ended
March 31, 2001.
Interest Expense, Net. Interest expense, net decreased to $189,000 for the
three months ended March 30, 2002 from $236,000 for the three months ended March
31, 2001. The decrease of $47,000 is primarily associated with a lower average
balance of debt outstanding during the three months ended March 30, 2002 as
compared to the corresponding period in 2001.
Income Tax Expense. The Company has a significant net operating loss
carryforward and as such provides for income taxes only to the extent that it
expects to pay cash taxes (primarily state taxes) for current income.
Net Income (Loss). The Company realized a net income of $426,000 for the
three months ended March 30, 2002 as compared to a net loss of $305,000 for the
three months ended March 31, 2001.
Dividends on Redeemable Convertible Preferred Stock. During the three
months ended March 30, 2002 the Company accrued $127,000 for cash dividends
payable to the redeemable convertible preferred stockholders. The dividends are
accruing pursuant to an agreement dated May 21, 2001 and are scheduled to be
paid at the earlier of the Company's following conditions, as outlined in the
letter with the redeemable convertible preferred stockholder:
8
(i) the merger, consolidation, reorganization, recapitalization, dissolution or
liquidation of the Company where the stockholders of the Company immediately
following the consummation of the merger no longer own more than 50% of the
voting securities of the Company; (ii) the sale, lease, exchange or other
transfer of all or substantially all of the assets of the Company; (iii) the
consummation of an equity financing by the Company in which proceeds to the
Company, net of transaction costs, are greater than or equal to $10,000,000;
(iv) the end of the first twelve month period in which earnings before income
taxes, depreciation and amortization are equal to or greater than $5,000,000; or
(v) or the refinancing of the Company's outstanding indebtedness to Fleet Bank.
The Company is presently unable to predict when the cash dividend will be paid.
Net Income (Loss) Attributable to Common Stockholders. The Company realized
a net income attributable to common stockholders of $299,000, or $0.01 per
share, for the three month period ended March 30, 2002 as compared to a net loss
of $305,000, or $0.03 per share, for the three month period ended March 31,
2001. The per share net income for the three months ended March 30, 2002 and the
per share loss for the three months ended March 31, 2001, were affected by an
increase in the number of outstanding shares of common stock primarily due to
the closing of the merger with Eyeshop and related stock purchase transactions
that occurred between May 23, 2001 and July 20, 2001.
LIQUIDITY AND CAPITAL RESOURCES
At March 30, 2002, the Company had $1,065,000 in cash and cash equivalents
and a working capital deficit of $6,401,000 in comparison to $1,356,000 in cash
and cash equivalents and working capital deficit of approximately $7,061,000
million as of December 29, 2001. The reduction in working capital deficit of
$660,000 is primarily due to the increase of accounts receivables and
inventories and a decrease in outstanding indebtedness. The largest portion of
the net working capital deficit at March 30, 2002 was debt of $7,870,000 that
matures on December 31, 2002. The Company may need to raise additional funds
during 2002 to replace maturing bank debt and may seek to raise those funds
through additional financings, including public or private equity offerings.
There can be no assurance that such funds will be available on terms acceptable
to the Company, if at all. If adequate funds are not available, the Company may
be required to limit its operations, which would have a material and adverse
affect on the Company. In addition, in its report on the Company's consolidated
financial statements as of and for the periods ended December 29, 2001, the
Company's independent auditors have expressed substantial doubt about the
Company's ability to continue as a going concern due to the Company's recurring
losses and its potential inability to pay its outstanding debts.
On March 26, 2001, the Company entered into a Third Modification Agreement
(as defined below) with Fleet Bank that, among other things, extended the
maturity date of the loans to December 31, 2002. The Third Modification
Agreement required that the Company obtain equity financing in the amount of
$1,000,000 by May 2001. On May 14, 2001, the Company entered into the Amended
and Restated Third Modification Agreement which extended the date for an equity
infusion from May 2001 to July 2001. In July 2001, the Company obtained equity
proceeds of $1,750,000.
Effective April 1, 1999, the Company acquired all of the outstanding shares
of capital stock of Kent Optical Company and its associated companies
(collectively, "Kent"). The purchase price paid in connection with this
acquisition was $5,209,000 in cash, $1,000,000 in notes payable over three years
and 160,000 shares of common stock. In addition, the Company offered to issue
additional consideration to the Kent stockholders if the market price of the
Company's common stock did not equal or exceed $5.00 per share at any time
during the period from April 23, 2000 to April 23, 2001, which the market price
of the common stock did not achieve. The amount of additional consideration due
to the Kent stockholders for each
9
share of common stock issued in the acquisition and held by them on April 23,
2001 is equal to the difference between $5.00 and the greater of (a) the market
price of the common stock on April 23, 2001 or (b) $2.73. At the Company's
option, the additional consideration may be paid to the Kent stockholders in
cash or in additional shares of the Company's common stock valued at its market
price on the date that the additional consideration becomes payable to the Kent
stockholders. At the time of acquisition, the Company included the value of this
additional consideration in its determination of the purchase price. As a result
of the Company's obligation to issue additional consideration to the former Kent
stockholders, on February 7, 2002, the Company entered into a settlement
agreement in which it agreed to pay such additional consideration by issuing
1,100,636 shares of its common stock to the former Kent stockholders. The shares
were issued on February 27, 2002. Also, as part of this settlement, the Company
renegotiated the terms of the remaining amounts owed under the notes payable.
As of March 30, 2002, the Company had warrants outstanding which provide it
with potential sources of financing as outlined below. However, because the
current market value of the Company's common stock is significantly less than
the exercise prices for most of the warrants with the greatest potential for
proceeds, it is unlikely that any significant proceeds will be realized by the
Company.
Exercise
Potential Price Expiration
Securities Number Proceeds Per Share Date
---------- --------- ---------- --------- ----
Carlyle Warrants....................................... 1,000,000 $200,000 $ 0.20 January 2009
Class II Warrants...................................... 679,684 2,100,224 3.09 November 2002
Bank Austria AG, f/k/a Creditanstalt, Warrants......... 150,000 693,750 4.63 December 2003
Fleet Warrants......................................... 50,000 25,500 0.51 August 2010
Fleet Warrants......................................... 50,000 7,810 0.16 December 2010
--------- ----------
1,929,684 $3,027,284
========= ==========
The Company also has outstanding 62,884 Class I Warrants. The Class I
Warrants entitle the holder to purchase an amount of shares of the Company's
common stock equal to an aggregate of up to 19.9% of the shares of common stock
purchasable under the Company's warrants and options outstanding as of October
9, 1997, which have not subsequently terminated or expired, on the same terms
and conditions of existing warrant and option holders. The purchaser is
obligated to exercise these warrants at the same time the options and warrants
of existing holders are exercised, subject to certain limitations. The amount of
proceeds from the exercise of these Class I Warrants cannot be estimated at this
time. However, for the same reasons stated above, it is unlikely that any
proceeds would be realized by the Company.
On April 15, 1999, the Company entered into a credit agreement (the "1999
Agreement") with Fleet National Bank ("Fleet") pursuant to which the Company
could borrow $10,000,000 on an acquisition line of credit, of which $7,000,000
is on a term loan basis and $3,000,000 is on a revolving line of credit basis,
subject to certain performance criteria and an asset-related borrowing base for
the revolver. The performance criteria include, among others, financial
condition covenants such as net worth requirements, indebtedness to net worth
ratios, debt service coverage ratios, funded debt coverage ratios, and pretax
profit, net profit and EBITDA requirements.
At December 25, 1999, the Company was not in compliance with the following
financial covenants of the 1999 Agreement: minimum net worth, minimum debt
service coverage, maximum funded debt service coverage and minimum net profit.
However, on March 31, 2000, the Company and Fleet entered into a modification
agreement (the "Original Modification Agreement") that amended the 1999
Agreement in order to, among other things, waive the Company's default, adjust
certain covenants to which the Company is subject and terminate the acquisition
line of credit. In addition, the Original Modification Agreement limited the
revolving line note to $2,500,000 and the term loan to $6,750,000 and
established the maturity date for each of these credit lines as March 31, 2001.
As part of the Original Modification Agreement, the Company issued to Fleet
warrants to purchase 50,000 shares of the Company's common stock at an exercise
price of $0.51 per share, which was equal to the average closing price of the
common stock for the last five trading days for the month of August 2000, and
warrants to purchase 50,000 shares of the Company's common stock at an exercise
price of $0.156 per share, which was equal to the average closing price of the
Company's common stock for the last five trading days for the month of December
2000. In August 2000, as a result of a bank merger, Sovereign Bank of New
England ("Sovereign") became the successor party to Fleet in the 1999 Agreement
and the Original Modification Agreement.
On November 30, 2000, the Company and Sovereign entered into a second
modification agreement (the "Second Modification Agreement") that amended the
terms of the Original Modification Agreement in order to, among other things,
defer certain payments required under the term note and amend certain terms and
conditions of the 1999 Agreement. At December 30, 2000, the Company was in
default for non-compliance with certain negative covenants contained in the
Second Modification Agreement relating to minimum net worth, minimum debt
service coverage, maximum funded debt service coverage and minimum net profit.
On March 26, 2001, the Company and Sovereign entered into the Third
Modification Agreement (the "Third Modification Agreement") that amended the
terms of the Original Modification Agreement and the Second Modification
Agreement in order to, among other things, waive the Company's default, adjust
or delete certain covenants to which the Company was subject, change the
repayment terms and extend the maturity date of the loans to December 31, 2002.
In addition, the Third Modification Agreement required that the Company close an
equity financing of at least $1,000,000 with third party investors on or before
May 31, 2001. The Third Modification Agreement established the following annual
interest rates for both the revolving line and term loans: (i) from February 1,
2001 through September 30, 2001 - six (6%) percent, (ii) from October 1, 2001
through December 31, 2001 - seven (7%) percent, (iii) from January 1, 2002
through December 31, 2002 - prime rate subject to a minimum rate of eight (8%)
percent and a maximum rate of eleven (11%) percent. The scheduled monthly
10
principal payments did not begin until July 1, 2001 and were set as $30,000 from
July 1, 2001 through December 31, 2001, and $100,000 from January 1, 2002
through December 31, 2002. On May 14, 2001, the Company entered into the Amended
and Restated Third Modification Agreement which restated the terms described
above and extended the date for which the Company was required to close an
equity financing to July 2001. In August 2001, Sovereign sold the loan back to
Fleet.
As of March 30, 2002, the Company's outstanding indebtedness under the 1999
Agreement was $2,500,000 under the revolving line of credit and $5,370,000 under
the term loan.
The Company was in compliance with the covenants contained in the Amended
and Restated Third Modification Agreement for the three months ended March 30,
2002. The Company has obtained waivers from the bank for all breaches of loan
covenants to date, but the Company may not receive waivers for any future
breaches that may occur. Any breach that is not waived may result in the bank
declaring the breach to be a default under the 1999 Agreement, which would
require immediate repayment of all outstanding principal and accrued interest at
a time when the Company may not be able to repay the bank.
On July 20, 2001, pursuant to an Agreement and Plan of Merger (the "Merger
Agreement") dated as of May 23, 2001 by and among the Company, Eyeshop
Acquisition Corporation, a Delaware corporation and wholly-owned subsidiary of
the Company ("EAC"), and eyeshop.com, inc. ("Eyeshop"), EAC merged with and into
Eyeshop (the "Merger") and Eyeshop became a wholly-owned subsidiary of the
Company.
Pursuant to the Merger Agreement, former Eyeshop stockholders are also
entitled to receive additional shares of the Company's common stock if and when
the options, warrants and other rights to receive the Company's common stock
that were held by the Company's security holders as of May 23, 2001 are
exercised. The Company issued a total of 7,306,662 shares of Common Stock to
former Eyeshop stockholders in connection with the Merger. Concurrently with the
Eyeshop merger, the Company assumed outstanding options under the Eyeshop stock
option plan to purchase up to an aggregate of 1,757,096 shares of the Company's
common stock.
RECENT ACCOUNTING PRONOUNCEMENTS
The Company adopted the provisions of Statement 141, effective July 1, 2001
and Statement 142, effective December 30, 2001. Statement 141 addresses
financial accounting and reporting for business combinations requiring the use
of the purchase method of accounting and reporting for goodwill and other
intangible assets requiring that goodwill and intangible assets with indefinite
useful lives no longer be amortized, but instead be tested for impairment at
least annually in accordance with the provisions of Statement 142. Under
Statement 142, the Company was required to reassess the useful lives and
residual values of all intangible assets acquired in purchase business
combinations, and make any necessary amortization period adjustments by the end
of the first interim period after adoption. In addition, to the extent an
intangible asset is identified as having an indefinite useful life, the Company
will be required to test the intangible asset for impairment in accordance with
the provisions of Statement 142 within the first interim period. Any impairment
loss will be measured as of the date of adoption and recognized as the
cumulative effect of a change in accounting principle in the first interim
period.
11
In connection with the transitional goodwill impairment evaluation,
Statement 142 requires the Company to perform an assessment of whether there is
an indication that goodwill (and equity-method goodwill), which totaled
$14,305,000 million at December 30, 2001, is impaired as of December 30, 2001,
the date of adoption. To accomplish this, the Company has identified its
reporting units and determined the carrying value of each reporting unit by
assigning the assets and liabilities, including the existing goodwill and
intangible assets, to those reporting units as of the date of adoption. The
Company has up to six months from the date of adoption to determine the fair
value of each reporting unit and compare it to the reporting unit's carrying
amount. To the extent a reporting unit's carrying amount exceeds its fair value,
an indication exists that the reporting unit's goodwill may be impaired and the
Company must perform the second step of the transitional impairment test. In the
second step, the Company must compare the implied fair value of the reporting
unit's goodwill, determined by allocating the reporting unit's fair value to all
of its assets (recognized and unrecognized) and liabilities in a manner similar
to a purchase price allocation in accordance with Statement 141, to its carrying
amount, both of which would be measured as of the date of adoption, which is
July 1, 2001 for the Company. This second step is required to be completed as
soon as possible, but no later than the end of the year of adoption. Any
transitional impairment loss will be recognized as the cumulative effect of a
change in accounting principle in the Company's statement of operations.
Based on preliminary independent third party enterprise valuations of each
of the Company's operating units, the Company does not expect to recognize any
impairment of its goodwill and intangible assets upon adoption of Statement 142.
During the second quarter 2002, the Company expects to finalize the enterprise
evaluations. Further, under the Statement 142's new guidelines, the Company
ceased amortization of its goodwill, which favorably impacts the first quarter
of 2002 by $261,000 compared to the prior year first quarter. During the three
months ended June 2002, the Company expects to finalize the enterprise
evaluations.
MANAGEMENT'S DISCUSSION OF CRITICAL ACCOUNTING POLICIES
In December 2001, the SEC requested that all registrants identify and
describe their most "critical accounting policies" in Management's Discussion
and Analysis. The SEC indicated that a "critical accounting policy" is one which
is both important to the portrayal of the company's financial condition and
results and requires management's most difficult, subjective or complex
judgments, often as a result of the need to make estimates about the effect of
matters that are inherently uncertain. The Company believes that the following
of the Company's accounting policies fit this definition.
Revenue Recognition and Allowance for Bad Debts
The Company recognizes revenue from the sale of eyewear at the time an
order is complete and revenue from eyecare services when the service is
performed. The Company has fee for service arrangements with most of its third
party payers. The Company recognizes revenue with third party payers net of
contractual allowances. The level of management judgment used to determine
revenue is small.
Because of various circumstances, such as changes in third party plan
contractual allowances, changes in patient co-pays, and goods or services denied
by third party payers, the Company reviews the agings of receivables from third
party payers and patients on at least a monthly basis. Sometimes claims have
incomplete or inaccurate information, and the Company re-submits those claims to
the third party payer. If amounts are denied by the third party payer and the
Company has recourse to the patient, the Company pursues payment from the
patient. Based on the Company's history of collectibility of older third party
payer and patient receivables, the Company provides a reserve for
uncollectibility.
12
At March 30, 2002 and December 29, 2001, the Company had reserved for 37% and
42% respectively of the gross amount of the outstanding third party payer and
patient receivables. If actual collectibility of these receivables is
significantly different from management's estimate, it could have a material
(favorable or unfavorable) result on the operating results and liquidity of the
Company.
Impairment of Long Lived Assets
The Company records impairment losses on long-lived assets when events and
circumstances indicate that the assets might be impaired and the undiscounted
cash flows estimated to be generated by those assets are less than the book
value of those items. The Company's cash flow estimates are based on historical
results adjusted to reflect the Company's best estimate of future market and
operating conditions. In performing this analysis, the Company considers such
factors as current results, trends and future prospects, in addition to other
economic factors. Based on those analyses during the years 1999 through 2001,
the Company did not record any charges for the impairment of long-lived assets.
At March 30, 2002, the Company had long-lived assets, including goodwill and
other intangibles of $19,605,000, property and equipment of $2,539,000, and web
site development costs of $2,288,000.
Conditions that could cause future impairment are deterioration of on-going
or forecasted operating results resulting from increased competition, a
recession in the United States or lack of liquidity causing the Company to limit
its operations. If one or more of these conditions occur, the future analyses
may indicate that certain long-lived assets are impaired, at which time the
Company would recognize an impairment charge. That impairment charge may be
material and have a significant impact on the Company's results of operations.
Further, the Company's software development relates to software acquired in
the Eyeshop merger. It was anticipated that, following the merger, available
cash resources of the combined companies would be devoted to continuation and
improvement of the business of the Company, with a decision to be made at a
future date as to when the Eyeshop development activities should be resumed. As
of March 30, 2002, no decision had been made to the timing of resuming Eyeshop
web site development activities. If the Company were to make a future decision
to not resume development of this web site, then it is possible that the Company
may have to recognize an impairment charge up to the entire amount of $2,288,000
and that charge may have a material impact on the Company's results of
operations.
Income Taxes
The Company has a history of unprofitable operations and these losses have
generated a sizeable federal tax net operating loss, or NOL, carryforward of
approximately $28,074,000 million as of December 29, 2001. Generally accepted
accounting principles require that the Company records a valuation allowance
against the deferred tax asset associated with this NOL if it is "more likely
than not" that the Company will not be able to utilize it to offset future
taxes. Due to the size of the NOL carryforward in relation to the Company's
history of unprofitable operations, the Company has not recognized any of this
net deferred tax asset. The Company currently provides for income taxes only to
the extent that it expects to pay cash taxes (primarily state taxes) for current
income.
It is possible, however, that the Company could be profitable in the future
at levels which cause management to conclude that it is more likely than not
that the Company will realize all or a portion of the NOL carryforward. Upon
reaching such a conclusion, the Company would immediately record the estimated
net realizable value of the deferred tax asset at that time and would then
provide for income taxes at a rate equal to the Company's combined federal and
state effective rates, which would
13
approximate 40% under current tax rates. Subsequent revisions to the estimated
net realizable value of the deferred tax asset could cause the Company's
provision for income taxes to vary significantly from period to period, although
the Company's cash tax payments would remain unaffected until the benefit of the
NOL is utilized.
BUSINESS RISKS AND CAUTIONARY STATEMENTS
Statements in this Quarterly Report on Form 10-Q under the caption
"Management's Discussion and Analysis of Financial Condition and Results of
Operations," as well as oral statements that may be made by the Company or by
officers, directors or employees of the Company acting on the Company's behalf,
that are not historical fact constitute "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that could cause the actual results of the Company to be
materially different from the historical results or from any results expressed
or implied by such forward-looking statements. Such factors include, but are not
limited to, the risk factors set forth below.
The Company does not intend to update any forward-looking statements to
reflect events or circumstances after the date of such statements or to reflect
the occurrence of anticipated or unanticipated events.
RISKS RELATED TO THE COMPANY'S BUSINESS
The Company had an accumulated deficit of $31,600,000 as of December 29, 2001,
and may never achieve or maintain profitability.
The Company has experienced losses in each year of operation since
inception in November 1992. For the fiscal year ended December 29, 2001, the
Company incurred a net loss of $5,500,000 bringing its accumulated deficit to
$31.6 million at December 29, 2001. The Company may never achieve profitability
and, if it achieves profitability, it may not be able to maintain profitability.
The Company's primary loan facilities expire at December 31, 2002 and the
Company may not be able to obtain financing or refinancing at terms acceptable
to the Company.
As of March 30, 2002, the Company owed Fleet Bank $2,500,000 under a
revolving loan and $5,700,000 under a term loan. Interest rates on the loans
during 2002 are at prime rate with a minimum of 8% and a maximum of 11% The
principal payments during 2002 on the term loan are $100,000 per month. Given
the Company's history, including substantial historical losses, the Company may
not be able to obtain financing or refinancing at terms acceptable to the
Company. The Company is making every effort to refinance these loans on terms
that are acceptable to the Company. The failure to obtain additional financing
would result in the declaration of a default with such loan facilities and could
materially and adversely affect the Company's business and financial condition.
Any additional equity financing, if available, may be dilutive to the Company's
stockholders and any debt financing, if available, may involve restrictions on
the Company's financing and operating activities.
The Company has previously breached certain loan covenants for which waivers of
such breaches have been granted, but the Company may not be able to obtain
waivers of any future breaches of loan covenants that may occur, which could
result in a default under existing or future loan agreements.
The Company has previously defaulted on a credit line agreement due to
non-compliance with negative covenants relating to minimum net worth, minimum
debt service coverage, maximum funded
14
debt service coverage and minimum net profit. The Company has obtained waivers
from the bank for all breaches of loan covenants to date, but future breaches
may occur for which the Company may not be able to obtain waivers. Any breach
that is not waived may result in the bank declaring the breach to be a default
under the loan agreement, which would require immediate repayment of all
outstanding principal and accrued interest at a time when the Company may not be
able to repay the bank. Accordingly, the declaration of a default under the loan
agreement could materially and adversely affect the Company's business and
financial condition.
The Company is dependent upon certain key management personnel and may not be
able to attract and retain additional personnel.
The Company's future success is dependent in part on the Company's
ability to retain certain key personnel, particularly E. Dean Butler, the
Company's Chairman and Carene S. Kunkler, the Company's President and Chief
Executive Officer, and the Company's ability to recruit and retain qualified
personnel over time. The Company may not be able to retain its existing
personnel or attract additional qualified employees in the future.
The primary eye care market is highly competitive. The Company's current and
potential competitors include many larger companies with substantially greater
financial, operating, marketing and support resources.
The optical industry is highly competitive and includes chains of
retail optical stores, multi-site eye care centers, and a large number of
individual opticians, optometrists and ophthalmologists who provide professional
services and/or dispense prescription eyewear. Because retailers of prescription
eyewear generally service local markets, competition varies substantially from
one location or geographic area to another. The Company believes that the
principal competitive factors affecting retailers of prescription eyewear are
location and convenience, quality and consistency of product and service, price,
product warranties, and a broad selection of merchandise. In the Company's
current regional markets, the Company faces competition from national and
regional retail optical chains which, in many cases, have greater financial
resources than the Company.
The Company may not be able to acquire new managed primary eye care contracts
and existing contracts may not be expanded in any meaningful way.
As an increasing percentage of optometric and ophthalmologic patients
are coming under the control of managed care entities, the Company believes that
its success will, in part, be dependent upon the Company's ability to negotiate,
on behalf of existing and prospective affiliated practices, contracts with HMOs,
employer groups and other private third party payors pursuant to which services
will be provided on a risk-sharing or capitated basis by some or all affiliated
practices. The proliferation of contracts that pass much of the risk of
providing care from the payor to the provider in markets the Company serves may
result in greater predictability of revenues, but greater unpredictability of
expenses. The Company may not be able to negotiate, on behalf of the affiliated
practices, satisfactory arrangements on a risk-sharing or capitated basis. In
addition, to the extent that patients or enrollees covered by such contracts
require more frequent or extensive care than anticipated, operating margins may
be reduced or, in the worst case, the revenues derived from such contracts may
be insufficient to cover the costs of the services provided. As a result,
affiliated practices may incur additional costs, which would reduce or eliminate
anticipated earnings under such contracts. Any such reduction or elimination of
earnings would have a material adverse affect on the Company's business and
results of operations.
15
The Company may be exposed to significant risk from liability claims if the
Company is unable to obtain insurance at acceptable costs or is otherwise unable
to protect itself against potential product liability claims.
The provision of professional eye care services entails an inherent
risk of professional malpractice and other similar claims. The Company does not
influence or control the practice of medicine or optometry by professionals or
have responsibility for compliance with certain regulatory and other
requirements directly applicable to individual professionals and professional
groups. As a result of the relationship between the Company's affiliated
practices and itself, the Company may become subject to some professional
malpractice actions under various theories. Claims, suits or complaints relating
to professional services provided by affiliated practices may be asserted
against the Company in the future.
The Company may not be able to retain adequate liability insurance at
reasonable rates and the Company's insurance may not be adequate to cover claims
asserted against it, in which event its business and results of operations may
be materially adversely affected.
The Company's operations and success are dependent upon its ability to enter
into agreements with health care providers.
Certain states prohibit the Company from practicing medicine, employing
physicians to practice medicine on the Company's behalf or employing
optometrists to render optometric services on the Company's behalf. Accordingly,
the success of the Company's operations as a full-service eye care provider
depends upon its ability to enter into agreements with health care providers,
including institutions, independent physicians and optometrists, to render
surgical and other professional services at facilities owned or managed by the
Company. The Company may not be able to enter into agreements with other health
care providers on satisfactory terms or such agreements may not be profitable to
the Company.
The Company is subject to extensive federal, state and local regulation, which
could materially affect the Company's operations.
The health care industry is highly regulated by federal, state and
local law. The regulatory environment in which the Company operates may change
significantly in the future. The Company expects to modify agreements and
operations from time to time as the business and regulatory environment changes.
Although the Company believes that its operations comply with applicable law,
the Company may not be able to address changes in the regulatory environment
successfully.
The Company's common stock was delisted from the Nasdaq Stock Market, which
makes it more difficult for stockholders to sell shares of the Company's common
stock.
On September 11, 2000, the Nasdaq National Market ("Nasdaq") terminated
the Company's listing on Nasdaq and the Company's common stock began trading on
the Over-the-Counter Bulletin Board (the "OTC"). Stockholders are likely to find
it more difficult to trade the Company's common stock on the OTC than on Nasdaq.
In order for the Company's common stock to resume trading on Nasdaq, the Company
must satisfy all of Nasdaq's requirements for initial listing, apply for listing
and be accepted for listing by Nasdaq. The Company does not currently satisfy
Nasdaq's initial listing requirements and may never satisfy Nasdaq's listing
requirements or, if the Company does satisfy such requirements in the future,
the Company's securities may not be accepted for listing by Nasdaq. If the
Company's securities are not accepted for listing on Nasdaq or another stock
exchange, it will also likely be more difficult for the Company to raise equity
capital.
16
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company has not entered into any transactions using derivative
financial instruments or derivative commodity instruments and believes that its
exposure to market risk associated with other financial instruments (such as
investments) is not material.
As of March 30, 2002, approximately $7,870,000 of the Company's debt
is subject to a floating interest rate and every 1% increase in the relevant
interest rate would adversely affect the Company on an annual basis by $79,000.
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
ON February 7, 2002, the Company, Kent Acquisition Corp., Timothy D.
Westra and John C. Cress entered into a Settlement Agreement in which each of
Messrs. Westra and Cress agreed to dismiss a complaint filed by them in Muskegon
County Circuit Court in Michigan on July 6, 2001 and removed to the United
States District Court for the Western District of Michigan (the "Lawsuit"). In
exchange for the dismissal of the Lawsuit and the release by each of Messrs.
Westra and Cress of any claims against the Company in connection with the
Lawsuit or their employment by the Company and in satisfaction of the Company's
obligations to Messrs. Westra and Cress in connection with the Company's
acquisition of all of the capital stock of Kent Optical Company and its
associated companies, the Company agreed to issue an aggregate of 1,100,606
shares of its Common Stock to them and to modify the terms of an aggregate
amount of $767,000 owed to Messrs. Westra and Cress to provide for, among other
things, an annual interest rate of 5.1% with monthly payments commencing
retroactively to January 2002 and ending December 2005.
ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS
On February 27, 2002, the Company issued an aggregate of 1,100,606
shares of its Common Stock, par value $.01 per share to John C. Cress and
Timothy D. Westra pursuant to a Settlement Agreement, dated February 7, 2002,
among the Company, each of Messrs. Westra and Cress and Kent Acquisition Corp.
No underwriters were involved in the transaction listed above. The shares were
issued as additional consideration in connection with the Company's acquisition
of all of the capital stock of Kent Optical Company and its associated
companies, effective April 1, 1999. The Company agreed to pay additional
consideration to each of Messrs. Westra and Cress if the market price of the
Company's Common Stock did not equal or exceed $5.00 at any time during the
period from April 23, 2000 to April 23, 2001. The market price of the Company's
Common Stock did not equal or exceed $5.00 during such period. Because the
shares were issued as additional consideration in connection with an
acquisition, the Company did not receive any cash proceeds. The Company relied
upon Section 4(2) of the Securities Act of 1933, as amended, because the above
transactions did not involve any public offering by the Company.
17
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Sight Resource Corporation
Date: May 14, 2002 By: /S/ CARENE S. KUNKLER
------------ --------------------------
Carene S. Kunkler
President and Chief Executive Officer
(duly authorized officer)
Date: May 14, 2002 By: /S/ DUANE D. KIMBLE, JR.
------------ -----------------------------
Duane D. Kimble, Jr.
Chief Financial Officer
(principal financial officer)
18